Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathy JR Berger, RM Levy, D Flomenhoft, M Dobbs Annals of neurology 44 (3), 341-349, 1998 | 243 | 1998 |
Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer’s disease patients and Aβ antibodies can enhance Aβ neurotoxicity A Nath, E Hall, M Tuzova, M Dobbs, M Jones, C Anderson, J Woodward, ... Neuromolecular medicine 3 (1), 29-39, 2003 | 143 | 2003 |
Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview S Grupke, J Hall, M Dobbs, GJ Bix, JF Fraser Clinical neurology and neurosurgery 129, 1-9, 2015 | 137 | 2015 |
Clinical Neurotoxicology E-Book: Syndromes, Substances, Environments MR Dobbs Elsevier Health Sciences, 2009 | 83 | 2009 |
Clinical Neurotoxicology E-Book: Syndromes, Substances, Environments MR Dobbs Elsevier Health Sciences, 2009 | 83 | 2009 |
Clinical Neurotoxicology E-Book: Syndromes, Substances, Environments MR Dobbs Elsevier Health Sciences, 2009 | 83 | 2009 |
Stroke in HIV infection and AIDS MR Dobbs, JR Berger Expert review of cardiovascular therapy 7 (10), 1263-1271, 2009 | 74 | 2009 |
The neurologic complications of scleromyxedema JR Berger, MR Dobbs, MH Terhune, WF Maragos Medicine 80 (5), 313-319, 2001 | 54 | 2001 |
Toxic encephalopathy MR Dobbs Seminars in neurology 31 (02), 184-193, 2011 | 48 | 2011 |
Cervical myelopathy secondary to violent tics of Tourette’s syndrome M Dobbs, JR Berger Neurology 60 (11), 1862-1866, 2003 | 48 | 2003 |
Neurobiological weapons PJ Osterbauer, MR Dobbs Neurologic clinics 23 (2), 599-621, 2005 | 19 | 2005 |
Neurobiological weapons PJ Osterbauer, MR Dobbs Neurologic clinics 23 (2), 599-621, 2005 | 19 | 2005 |
The Prevalence of Multiple Comorbidities in Stroke Survivors in Rural Appalachia and the Clinical Care Implications PH Kitzman, KM Sutton, M Wolfe, L Bellamy, MR Dobbs Journal of Stroke and Cerebrovascular Diseases 28 (11), 104358, 2019 | 18 | 2019 |
Composition and method for control and treatment of cutaneous inflammation MR Dobbs, TR McArthur US Patent 6,300,326, 2001 | 11 | 2001 |
Episode-based payment for ischemic stroke care with implications for neurologists MR Dobbs Neurology: Clinical Practice 4 (3), 231-238, 2014 | 10 | 2014 |
Comparing the Trends of Elevated Blood Pressure in Appalachian and NonAppalachian Regions AL ShanderaOchsner, DY Han, D Rose, SR Aroor, F Schmitt, ... The Journal of Clinical Hypertension 16 (10), 713-715, 2014 | 8 | 2014 |
Innovation in Stroke Care Quality: NIH Stroke Scale Change and Shewhart Charts MR Dobbs, P Krishnamohan, G Jicha, AP Cohen Quality Management in Healthcare 24 (3), 135-139, 2015 | 6 | 2015 |
Tetanus toxin DB Burtis, MR Dobbs Clinical Neurotoxicology, 427-435, 2009 | 6 | 2009 |
Bilateral abducens nerve palsy from mild trauma with force applied at an oblique angle: a case report and review of the literature. M Dobbs, T Fakhoury The Journal of the Kentucky Medical Association 101 (11), 507-510, 2003 | 6 | 2003 |
Toxin-induced cerebellar disorders K Dolbec, MR Dobbs, M Ibraheem Neurologic clinics 38 (4), 843-852, 2020 | 5 | 2020 |